SCHEMBL2098756

SCHEMBL2098756

N#Cc1ccc(N2C3CCC2CC(NC(=O)C2(c4ccc(Cl)cc4)CC2)C3)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 2/20 0.45
CCR6 P51684 1/20 0.41
KIT P10721 1/20 0.40
KCNH2 Q12809 2/20 0.38
HSP90AA1 P07900 3/20 0.38
HSP90AB1 P08238 3/20 0.38
TMPRSS4 Q9NRS4 1/20 0.37
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RET P07949 1/20 0.36
TACR3 P29371 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
DPP4 P27487 2/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2098753 1.00 AVPR1A (0.45) AVPR1ACCR6KITKCNH2HSP90AA1
SCHEMBL2096814 0.86 AVPR1A (0.44) AVPR1AKITKCNH2LMNAL3MBTL1
SCHEMBL1117110 0.86 AVPR1A (0.44) AVPR1AKITKCNH2LMNAL3MBTL1
SCHEMBL2096988 0.85 AVPR1A (0.47) AVPR1AKITKCNH2HSP90AA1HSP90AB1
SCHEMBL2097902 0.85 AVPR1A (0.47) AVPR1AKITKCNH2HSP90AA1HSP90AB1
SCHEMBL1116560 0.85 HSP90AA1 (0.47) AVPR1AKITKCNH2HSP90AA1HSP90AB1
SCHEMBL1116559 0.85 HSP90AA1 (0.47) AVPR1AKITKCNH2HSP90AA1HSP90AB1
SCHEMBL2098543 0.84 HSP90AA1 (0.51) AVPR1AHSP90AA1HSP90AB1MEN1KMT2A
SCHEMBL2097261 0.84 HSP90AA1 (0.48) AVPR1AKITKCNH2HSP90AA1HSP90AB1
SCHEMBL2099002 0.84 HSP90AA1 (0.51) AVPR1AHSP90AA1HSP90AB1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163771-B2 11 β-HSD1 modulators EXELIXIS, INC. (US) 2012-04-24 US disclosed
US-8163771-B2 11 β-HSD1 modulators EXELIXIS, INC. (US) 2012-04-24 US disclosed
US-8163771-B2 11 β-HSD1 modulators EXELIXIS, INC. (US) 2012-04-24 US disclosed
US-20100105675-A2 11 BETA-HSD1 MODULATORS EXELIXIS, INC. (US) 2010-04-29 US disclosed
US-20100105675-A2 11 BETA-HSD1 MODULATORS EXELIXIS, INC. (US) 2010-04-29 US disclosed
US-20100105675-A2 11 BETA-HSD1 MODULATORS EXELIXIS, INC. (US) 2010-04-29 US disclosed
US-20090247515-A1 11 Beta-HSD1 Modulators EXELIXIS, INC. (US) 2009-10-01 US disclosed
US-20090247515-A1 11 Beta-HSD1 Modulators EXELIXIS, INC. (US) 2009-10-01 US disclosed
US-20090247515-A1 11 Beta-HSD1 Modulators EXELIXIS, INC. (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105675-A2 11 BETA-HSD1 MODULATORS HSD11B1, HSD11B2, HSD3B1 AVPR1A 317/4885CCR6 3539/4885KIT 4367/4885
US-20090247515-A1 11 Beta-HSD1 Modulators HSD11B1, HSD11B2, HSD3B1 AVPR1A 311/4885CCR6 3838/4885KIT 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.